Albert DeFelice

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Pulmonary arterial hypertension (PAH) remains a life-limiting condition with a major impact on the ability to lead a normal life. Although existing therapies may improve the outlook in some patients there remains a major unmet need to develop more effective therapies in this condition. There have been significant advances in our understanding of the(More)
  • 1